Enforcement Report - Week of June 7, 2023
NEW DELHI: Announcing that samples of four cough and cold syrups manufactured by Maiden Pharmaceutical Ltd – an Indian firm – that were linked to the deaths of 66 children in Gambia have been found to be of standard quality, the government in a letter slammed WHO for failing to substantiate its charge that the India-made products caused the deaths in the African country.
Central Drugs Standard Control Organisation is investigating the deaths of dozens of children in The Gambia that the World Health Organisation (WHO) said may be linked to a cough syrup made in the south Asian nation.
Enforcement Report - Week of September 29, 2021
Enforcement Report - Week of February 6, 2019
Charleston Laboratories, Inc. is a privately held, specialty pharmaceutical company focused on the research and development of novel pain products that prevent the burdensome side effects related to opioid analgesics and other products. In August 2014, Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. entered into a strategic collaboration for the development and commercialization for the US of hydrocodone combination products, including CL-108.